Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

615 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales.
Bedston S, Almaghrabi F, Patterson L, Agrawal U, Woolford L, Anand SN, Joy M, Crawford A, Goudie R, Byford R, Abbasizanjani H, Smith D, Laidlaw L, Akbari A, Sullivan C, Bradley DT, Lyons RA, de Lusignan S, Hobbs FDR, Robertson C, Sheikh SA, Shi T. Bedston S, et al. Among authors: de lusignan s. Lancet Reg Health Eur. 2023 Dec 12;37:100816. doi: 10.1016/j.lanepe.2023.100816. eCollection 2024 Feb. Lancet Reg Health Eur. 2023. PMID: 38162515 Free PMC article.
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study.
Whitaker HJ, Tsang RSM, Byford R, Aspden C, Button E, Sebastian Pillai P, Jamie G, Kar D, Williams J, Sinnathamby M, Marsden G, Elson WH, Leston M, Anand S, Okusi C, Fan X, Linley E, Rowe C, DArcangelo S, Otter AD, Ellis J, Hobbs FDR, Tzortziou-Brown V, Zambon M, Ramsay M, Brown KE, Amirthalingam G, Andrews NJ, de Lusignan S, Lopez Bernal J. Whitaker HJ, et al. Among authors: de lusignan s. J Infect. 2023 Oct;87(4):315-327. doi: 10.1016/j.jinf.2023.08.005. Epub 2023 Aug 12. J Infect. 2023. PMID: 37579793 Free article.
Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort.
Joy M, Agrawal U, Fan X, Robertson C, Anand SN, Ordonez-Mena J, Byford R, Goudie R, Jamie G, Kar D, Williams J, Marsden GL, Tzortziou-Brown V, Sheikh SA, Hobbs FDR, de Lusignan S. Joy M, et al. Among authors: de lusignan s. Lancet Reg Health Eur. 2023 Jul 18;32:100681. doi: 10.1016/j.lanepe.2023.100681. eCollection 2023 Sep. Lancet Reg Health Eur. 2023. PMID: 37671127 Free PMC article.
Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study.
Forbes AK, Hinton W, Feher MD, Elson W, Joy M, Ordóñez-Mena JM, Fan X, Cole NI, Banerjee D, Suckling RJ, de Lusignan S, Swift PA. Forbes AK, et al. Among authors: de lusignan s. EClinicalMedicine. 2024 Jan 19;68:102426. doi: 10.1016/j.eclinm.2024.102426. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38304744 Free PMC article.
Influenza vaccination during the 2021/22 season: A data-linkage test-negative case-control study of effectiveness against influenza requiring emergency care in England and serological analysis of primary care patients.
Whitaker HJ, Hassell K, Hoschler K, Power L, Stowe J, Boddington NL, Tsang C, Zhao H, Linley E, Button E, Okusi C, Aspden C, Byford R, deLusignan S, Amirthalingam G, Zambon M, Andrews NJ, Watson C. Whitaker HJ, et al. Vaccine. 2024 Mar 7;42(7):1656-1664. doi: 10.1016/j.vaccine.2024.02.006. Epub 2024 Feb 10. Vaccine. 2024. PMID: 38342716
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.
Meeraus W, Joy M, Ouwens M, Taylor KS, Venkatesan S, Dennis J, Tran TN, Dashtban A, Fan X, Williams R, Morris T, Carty L, Kar D, Hoang U, Feher M, Forbes A, Jamie G, Hinton W, Sanecka K, Byford R, Anand SN, Hobbs FDR, Clifton DA, Pollard AJ, Taylor S, de Lusignan S. Meeraus W, et al. Among authors: de lusignan s. J Infect. 2024 Apr;88(4):106129. doi: 10.1016/j.jinf.2024.106129. Epub 2024 Feb 29. J Infect. 2024. PMID: 38431156 Free article.
Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19).
Fanshawe TR, Tonner S, Turner PJ, Cogdale J, Glogowska M, de Lusignan S, Okusi C, Perera R, Sebastianpillai P, Williams A, Zambon M, Nicholson BD, Hobbs FDR, Hayward GN; RAPTOR-C19 Study Group. Fanshawe TR, et al. Among authors: de lusignan s. Clin Microbiol Infect. 2024 Mar;30(3):380-386. doi: 10.1016/j.cmi.2023.12.009. Epub 2023 Dec 15. Clin Microbiol Infect. 2024. PMID: 38103638 Free article.
Primary and secondary care service use and costs associated with frailty in an ageing population: longitudinal analysis of an English primary care cohort of adults aged 50 and over, 2006-2017.
Fogg C, England T, Zhu S, Jones J, de Lusignan S, Fraser SDS, Roderick P, Clegg A, Harris S, Brailsford S, Barkham A, Patel HP, Walsh B. Fogg C, et al. Among authors: de lusignan s. Age Ageing. 2024 Feb 1;53(2):afae010. doi: 10.1093/ageing/afae010. Age Ageing. 2024. PMID: 38337044 Free PMC article.
615 results